Annovera™ Drug-Drug Interaction Study

NCT04290390 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

TherapeuticsMD